| 摘要 |
Compositions comprising purified gadolinium-exchanged carboxylate-alumoxane nanoparticles in an aqueous solution are provided for use as MRI contrast agents. Targeted imaging is provided by nanoparticles comprising surface-bound antibodies specific for biomolecules present in a patient.
|
